PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Vvedenskaya, O.* ; Rose, T.D.* ; Knittelfelder, O.* ; Palladini, A. ; Wodke, J.A.H.* ; Schumann, K.* ; Ackerman, J.M.* ; Wang, Y.* ; Has, C.* ; Brosch, M.* ; Thangapandi, V.R.* ; Buch, S.* ; Züllig, T.* ; Hartler, J.* ; Köfeler, H.C.* ; Röcken, C.* ; Coskun, Ü. ; Klipp, E.* ; von Schoenfels, W.* ; Gross, J.* ; Schafmayer, C.* ; Hampe, J.* ; Pauling, J.K.* ; Shevchenko, A.*

Non-alcoholic fatty liver disease Stratification by Liver Lipidomics.

J. Lipid Res. 62:100104 (2021)
Verlagsversion Forschungsdaten DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
Non-alcoholic fatty liver disease (NAFLD) is a common metabolic dysfunction leading to hepatic steatosis. However, NAFLD's global impact on the liver lipidome is poorly understood. Using high-resolution shotgun mass spectrometry, we quantified the molar abundance of 316 species from 22 major lipid classes in liver biopsies of 365 patients, including non-steatotic patients with normal or excessive weight, patients diagnosed with NAFL (non-alcoholic fatty liver) or NASH (non-alcoholic steatohepatitis), and patients bearing common mutations of NAFLD-related protein factors. We confirmed the progressive accumulation of di- and tri- acylglycerols and cholesteryl esters in the liver of NAFL and NASH patients, while the bulk composition of glycerophospho- and sphingolipids remained unchanged. Further stratification by biclustering analysis identified sphingomyelin species comprising n24:2 fatty acid moieties as membrane lipid markers of NAFLD. Normalized relative abundance of sphingomyelins SM 43:3;2 and SM 43:1;2 containing n24:2 and n24:0 fatty acid moieties, respectively, showed opposite trends during NAFLD progression and distinguished NAFL and NASH lipidomes from the lipidome of non-steatoic livers. Together with several glycerophospholipids containing a C22:6 fatty acid moiety, these lipids serve as markers of early and advanced stages of NAFL.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
5.922
0.000
2
1
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Nafl ; Nafld ; Nash ; Biclustering Analysis ; Lipid Biomarkers ; Liver Biopsies ; Liver Lipidome ; Shotgun Lipidomics ; Sphingomyelins ; Steatosis; De-novo Lipogenesis; Shotgun Lipidomics; Mass-spectrometry; Blood-plasma; Resolution; Pnpla3; Sphingolipids; Mboat7; Derivatization; Identification
Sprache englisch
Veröffentlichungsjahr 2021
HGF-Berichtsjahr 2021
ISSN (print) / ISBN 0022-2275
e-ISSN 1539-7262
Zeitschrift Journal of Lipid Research
Quellenangaben Band: 62, Heft: , Seiten: , Artikelnummer: 100104 Supplement: ,
Verlag American Society for Biochemistry and Molecular Biology
Verlagsort Radarweg 29, 1043 Nx Amsterdam, Netherlands
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Pancreatic Islet Research (IPI)
POF Topic(s) 90000 - German Center for Diabetes Research
Forschungsfeld(er) Helmholtz Diabetes Center
PSP-Element(e) G-502600-002
Förderungen Deutsche Forschungsgemeinschaft (DFG)
University of Graz
HRSM project "Explorative Lipidomics seltener und chronischer Krankheiten''
Austrian Federal Ministry of Education, Science and Research
Bavarian State Ministry of Science and the Arts
German Federal Ministry of Education and Research (BMBF)
Lipidomics and Informatics for Life Sciences (LIFS) unit of de.nBi consortium
German Ministry of Research and Education (BmBF) through the Liver Systems Medicine (LiSyM) network grant
DOI 10.1016/j.jlr.2021.100104
WOS ID WOS:000703593800001
Scopus ID 85117144822
PubMed ID 34384788
Erfassungsdatum 2021-10-06
[➜Korrektur melden]